• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿科门诊抗生素处方的最佳选择。

Optimal Pediatric Outpatient Antibiotic Prescribing.

机构信息

Division of Infectious Diseases, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee.

Healthcare-Associated Infections and Antimicrobial Resistance Program of the Communicable and Environmental Diseases and Emergency Preparedness Division, Tennessee Department of Health, Nashville.

出版信息

JAMA Netw Open. 2024 Oct 1;7(10):e2437409. doi: 10.1001/jamanetworkopen.2024.37409.

DOI:10.1001/jamanetworkopen.2024.37409
PMID:39361280
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11450517/
Abstract

IMPORTANCE

In the US, 50% of all pediatric outpatient antibiotics prescribed are unnecessary or inappropriate. Less is known about the appropriateness of pediatric outpatient antibiotic prescribing.

OBJECTIVE

To identify the overall percentage of outpatient antibiotic prescriptions that are optimal according to guideline recommendations for first-line antibiotic choice and duration.

DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study obtained data on any clinical encounter for a patient younger than 20 years with at least 1 outpatient oral antibiotic, intramuscular ceftriaxone, or penicillin prescription filled in the state of Tennessee from January 1 to December 31, 2022, from IQVIA's Longitudinal Prescription Claims and Medical Claims databases. Each clinical encounter was assigned a single diagnosis corresponding to the lowest applicable tier in a 3-tier antibiotic tier system. Antibiotics prescribed for tier 1 (nearly always required) or tier 2 (sometimes required) diagnoses were compared with published national guidelines. Antibiotics prescribed for tier 3 (rarely ever required) diagnoses were considered to be suboptimal for both choice and duration.

MAIN OUTCOMES AND MEASURES

Primary outcome was the percentage of optimal antibiotic prescriptions consistent with guideline recommendations for first-line antibiotic choice and duration. Secondary outcomes were the associations of optimal prescribing by diagnosis, suboptimal antibiotic choice, and patient- and clinician-level factors (ie, age and Social Vulnerability Index) with optimal antibiotic choice, which were measured by odds ratios (ORs) and 95% CIs calculated using a multivariable logistic regression model.

RESULTS

A total of 506 633 antibiotics were prescribed in 488 818 clinical encounters (for 247 843 females [50.7%]; mean [SD] age, 8.36 [5.5] years). Of these antibiotics, 21 055 (4.2%) were for tier 1 diagnoses, 288 044 (56.9%) for tier 2 diagnoses, and 197 660 (39.0%) for tier 3 diagnoses. Additionally, 194 906 antibiotics (38.5%) were optimal for antibiotic choice, 259 786 (51.3%) for duration, and 159 050 (31.4%) for both choice and duration. Acute otitis media (AOM) and pharyngitis were the most common indications, with 85 635 of 127 312 (67.3%) clinical encounters for AOM and 42 969 of 76 865 (55.9%) clinical encounters for pharyngitis being optimal for antibiotic choice. Only 257 of 4472 (5.7%) antibiotics prescribed for community-acquired pneumonia had a 5-day duration. Optimal antibiotic choice was more likely in patients who were younger (OR, 0.98; 95% CI, 0.98-0.98) and were less socially vulnerable (OR, 0.84; 95% CI, 0.82-0.86).

CONCLUSIONS AND RELEVANCE

This cross-sectional study found that less than one-third of antibiotics prescribed to pediatric outpatients in Tennessee were optimal for choice and duration. Four stewardship interventions may be targeted: (1) reduce the number of prescriptions for tier 3 diagnoses, (2) increase optimal prescribing for AOM and pharyngitis, (3) provide clinician education on shorter antibiotic treatment courses for community-acquired pneumonia, and (4) promote optimal antibiotic prescribing in resource-limited settings.

摘要

重要性

在美国,50%的儿科门诊开出的抗生素是不必要或不适当的。关于儿科门诊抗生素处方的适当性,人们了解得较少。

目的

确定根据一线抗生素选择和持续时间的指南建议,门诊抗生素处方中最佳处方的总体百分比。

设计、地点和参与者:这项横断面研究从 IQVIA 的纵向处方和医疗索赔数据库中获取了 2022 年 1 月 1 日至 12 月 31 日期间田纳西州每个年龄小于 20 岁的患者至少有 1 次门诊口服抗生素、肌内头孢曲松或青霉素处方的任何临床就诊的数据。每个临床就诊都分配了一个与 3 级抗生素分层系统中最低适用层相对应的单一诊断。对于 1 级(几乎总是需要)或 2 级(有时需要)诊断开出的抗生素与公布的国家指南进行了比较。对于 3 级(很少需要)诊断开出的抗生素,无论是选择还是持续时间,都被认为是不合适的。

主要结果和措施

主要结果是与指南建议的一线抗生素选择和持续时间一致的最佳抗生素处方的百分比。次要结果是根据诊断、抗生素选择不佳和患者和临床医生水平因素(即年龄和社会脆弱性指数)进行最佳抗生素选择的关联,这些关联通过使用多变量逻辑回归模型计算的比值比(OR)和 95%置信区间进行测量。

结果

在 488818 次临床就诊中开出了 506633 次抗生素(247843 名女性[50.7%];平均[SD]年龄为 8.36[5.5]岁)。在这些抗生素中,21055 次(4.2%)用于 1 级诊断,288044 次(56.9%)用于 2 级诊断,197660 次(39.0%)用于 3 级诊断。此外,194906 次抗生素(38.5%)在抗生素选择方面是最佳的,259786 次(51.3%)在持续时间方面是最佳的,159050 次(31.4%)在选择和持续时间方面都是最佳的。急性中耳炎(AOM)和咽炎是最常见的适应症,127312 次临床就诊中有 85635 次(67.3%)为 AOM,76865 次临床就诊中有 42969 次(55.9%)为咽炎的抗生素选择是最佳的。只有 4472 次抗生素中的 257 次(5.7%)用于社区获得性肺炎,持续时间为 5 天。在年龄较小(OR,0.98;95%CI,0.98-0.98)和社会脆弱性较低的患者中,更有可能选择最佳抗生素(OR,0.84;95%CI,0.82-0.86)。

结论和相关性

这项横断面研究发现,田纳西州儿科门诊开出的抗生素中,不到三分之一是最佳选择和持续时间。可能有四个管理干预措施需要针对:(1)减少 3 级诊断的处方数量,(2)增加 AOM 和咽炎的最佳处方,(3)为社区获得性肺炎提供较短抗生素治疗疗程的临床医生教育,以及(4)促进资源有限环境中的最佳抗生素处方。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8569/11450517/572ed13a4826/jamanetwopen-e2437409-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8569/11450517/d959253e474b/jamanetwopen-e2437409-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8569/11450517/bd45e75ceb45/jamanetwopen-e2437409-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8569/11450517/572ed13a4826/jamanetwopen-e2437409-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8569/11450517/d959253e474b/jamanetwopen-e2437409-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8569/11450517/bd45e75ceb45/jamanetwopen-e2437409-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8569/11450517/572ed13a4826/jamanetwopen-e2437409-g003.jpg

相似文献

1
Optimal Pediatric Outpatient Antibiotic Prescribing.儿科门诊抗生素处方的最佳选择。
JAMA Netw Open. 2024 Oct 1;7(10):e2437409. doi: 10.1001/jamanetworkopen.2024.37409.
2
Immediate versus delayed versus no antibiotics for respiratory infections.即刻与延迟用与不用抗生素治疗呼吸道感染。
Cochrane Database Syst Rev. 2023 Oct 4;10(10):CD004417. doi: 10.1002/14651858.CD004417.pub6.
3
Delayed antibiotic prescriptions for respiratory infections.呼吸道感染的延迟抗生素处方
Cochrane Database Syst Rev. 2017 Sep 7;9(9):CD004417. doi: 10.1002/14651858.CD004417.pub5.
4
Interventions to improve antibiotic prescribing practices in ambulatory care.改善门诊医疗中抗生素处方行为的干预措施。
Cochrane Database Syst Rev. 2005 Oct 19;2005(4):CD003539. doi: 10.1002/14651858.CD003539.pub2.
5
Prevalence of Antibiotic Prescribing for Acute Respiratory Tract Infection in Telehealth Versus Face-to-Face Consultations: Cross-Sectional Analysis of General Practice Registrars' Clinical Practice.远程医疗与面对面咨询中急性呼吸道感染抗生素处方的患病率:全科医生注册学员临床实践的横断面分析
J Med Internet Res. 2025 Mar 13;27:e60831. doi: 10.2196/60831.
6
Interventions to improve antibiotic prescribing practices for hospital inpatients.改善医院住院患者抗生素处方行为的干预措施。
Cochrane Database Syst Rev. 2017 Feb 9;2(2):CD003543. doi: 10.1002/14651858.CD003543.pub4.
7
Delayed antibiotics for symptoms and complications of respiratory infections.针对呼吸道感染症状及并发症延迟使用抗生素。
Cochrane Database Syst Rev. 2004 Oct 18(4):CD004417. doi: 10.1002/14651858.CD004417.pub2.
8
Clinician-targeted interventions to influence antibiotic prescribing behaviour for acute respiratory infections in primary care: an overview of systematic reviews.针对临床医生的干预措施对基层医疗中急性呼吸道感染抗生素处方行为的影响:系统评价概述
Cochrane Database Syst Rev. 2017 Sep 7;9(9):CD012252. doi: 10.1002/14651858.CD012252.pub2.
9
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
10
Topical antibiotics for chronic suppurative otitis media.用于慢性化脓性中耳炎的局部用抗生素
Cochrane Database Syst Rev. 2025 Jun 9;6:CD013051. doi: 10.1002/14651858.CD013051.pub3.

引用本文的文献

1
Assessing insurance claims as a measure for outpatient antimicrobial stewardship.评估保险理赔情况作为门诊抗菌药物管理的一项措施。
Antimicrob Steward Healthc Epidemiol. 2025 Jun 30;5(1):e141. doi: 10.1017/ash.2025.10042. eCollection 2025.
2
Empiric: A Card Game for Guideline-Based Antibiotic Prescribing Used for Continuing Medical Education.经验性用药:一款用于继续医学教育的基于指南的抗生素处方纸牌游戏。
MedEdPORTAL. 2025 Jun 10;21:11533. doi: 10.15766/mep_2374-8265.11533. eCollection 2025.

本文引用的文献

1
Ambulatory amoxicillin use for common acute respiratory infections during a national shortage: Results from the SHARPS-OP benchmarking collaborative.在全国性短缺期间门诊使用阿莫西林治疗常见急性呼吸道感染:SHARPS-OP基准协作研究结果
Am J Infect Control. 2024 May;52(5):614-617. doi: 10.1016/j.ajic.2023.12.014. Epub 2023 Dec 27.
2
Appropriateness of antibiotic prescribing varies by clinical services at United States children's hospitals.美国儿童医院的临床科室不同,抗生素处方的适宜性也有所不同。
Infect Control Hosp Epidemiol. 2023 Nov;44(11):1711-1717. doi: 10.1017/ice.2023.56. Epub 2023 Apr 12.
3
Beyond antibiotic prescribing rates: first-line antibiotic selection, prescription duration, and associated factors for respiratory encounters in urgent care.
超越抗生素处方率:紧急护理中呼吸道疾病就诊的一线抗生素选择、处方持续时间及相关因素
Antimicrob Steward Healthc Epidemiol. 2023 Sep 5;3(1):e146. doi: 10.1017/ash.2023.416. eCollection 2023.
4
Short-Course Therapy for Urinary Tract Infections in Children: The SCOUT Randomized Clinical Trial.儿童尿路感染的短程治疗:SCOUT 随机临床试验。
JAMA Pediatr. 2023 Aug 1;177(8):782-789. doi: 10.1001/jamapediatrics.2023.1979.
5
Inclusion, diversity, access, and equity in antimicrobial stewardship: where we are and where we are headed.抗菌药物管理中的纳入、多样性、可及性与公平性:我们所处的位置及前进方向。
Curr Opin Infect Dis. 2023 Aug 1;36(4):281-287. doi: 10.1097/QCO.0000000000000934. Epub 2023 Jun 6.
6
Antibiotics in the pathogenesis of diabetes and inflammatory diseases of the gastrointestinal tract.抗生素在糖尿病和胃肠道炎症性疾病发病机制中的作用。
Nat Rev Gastroenterol Hepatol. 2023 Feb;20(2):81-100. doi: 10.1038/s41575-022-00685-9. Epub 2022 Oct 18.
7
The Evolution of Our Understanding of Penicillin Allergy: 1942-2022.青霉素过敏认识的演变:1942-2022 年。
J Allergy Clin Immunol Pract. 2023 Feb;11(2):405-413. doi: 10.1016/j.jaip.2022.09.006. Epub 2022 Sep 15.
8
Amoxicillin Versus Other Antibiotic Agents for the Treatment of Acute Otitis Media in Children.阿莫西林与其他抗生素药物治疗儿童急性中耳炎的疗效比较。
J Pediatr. 2022 Dec;251:98-104.e5. doi: 10.1016/j.jpeds.2022.07.053. Epub 2022 Aug 6.
9
Short- vs Standard-Course Outpatient Antibiotic Therapy for Community-Acquired Pneumonia in Children: The SCOUT-CAP Randomized Clinical Trial.儿童社区获得性肺炎的短疗程与标准疗程门诊抗生素治疗:SCOUT-CAP 随机临床试验。
JAMA Pediatr. 2022 Mar 1;176(3):253-261. doi: 10.1001/jamapediatrics.2021.5547.
10
Effect of Amoxicillin Dose and Treatment Duration on the Need for Antibiotic Re-treatment in Children With Community-Acquired Pneumonia: The CAP-IT Randomized Clinical Trial.阿莫西林剂量和疗程对儿童社区获得性肺炎抗生素再次治疗需求的影响:CAP-IT 随机临床试验。
JAMA. 2021 Nov 2;326(17):1713-1724. doi: 10.1001/jama.2021.17843.